Yingling Zu

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Randomized Controlled Trial

Stem Cell Transplantation

Cross Sectional

Acute Lymphoblastic Leukemia

Top Venues

Blood cancer journal

British journal of haematology

Therapeutic advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Fei Yang, Quan Ren, Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Baijun Fang, Yuewen Fu, Yongliang Wang, Yanyan Liu, Lina Zhang, Wenli Zuo, Yufu Li, Quande Lin, Huifang Zhao, Ping Wang, Binglei Zhang, Zhenghua Huang, Yong-Ping Song, Jian Zhou
Multiple small-dose infusions of G-CSF-mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia. British journal of haematology (2024)
Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Pei Li, Ying Liu, Xiaofeng Dong, Jian Zhou
Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease. Therapeutic advances in hematology 15 (2024)
Fei Yang, Quan Ren, Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Baijun Fang, Yuewen Fu, Yongliang Wang, Yanyan Liu, Lina Zhang, Wenli Zuo, Yufu Li, Quande Lin, Huifang Zhao, Ping Wang, Binglei Zhang, Zhenghua Huang, Yong-Ping Song, Jian Zhou
Multiple small-dose infusions of G-CSF-mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia. British journal of haematology 205 (2) (2024)
Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial. Blood cancer journal 13 (1) (2023)
Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial. Blood cancer journal 13 (1) (2023)
Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial. Blood cancer journal 13 (1) (2023)
Yingling Zu, Ruirui Gui, Zhen Li, Juan Wang, Yanli Zhang, Fengkuan Yu, Huifang Zhao, Xinrong Zhan, Zhongliang Wang, Pengtao Xing, Xianjing Wang, Huili Wang, Yongping Song, Jian Zhou
Low-dose PTCy plus low-dose ATG as GVHD prophylaxis after UD-PBSCT for hematologic malignancies: a prospective, multicenter, randomized controlled trial. Blood cancer journal 13 (1) (2023)
Wenli Zhang, Ruirui Gui, Yingling Zu, Binglei Zhang, Zhen Li, Yanli Zhang, Xianjing Wang, Shuli Guo, Xinrong Zhan, Yuewen Fu, Yong-Ping Song, Jian Zhou
Reduced-dose post-transplant cyclophosphamide plus low-dose post-transplant anti-thymocyte globulin as graft-versus-host disease prophylaxis with fludarabine-busulfan-cytarabine conditioning in haploidentical peripheral blood stem cell transplantation: A multicentre, randomized controlled clinical trial. British journal of haematology (2022)